Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

ILLUMINA, INC.

(ILMN)
  Report
Delayed Quote. Delayed Nasdaq - 10/23 04:00:00 pm
323.55 USD   -0.73%
10/07ILLUMINA, INC. : Report
CO
10/05ILLUMINA, INC. : Report
CO
10/01ILLUMINA, INC. : Report
CO
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/19/2020 10/20/2020 10/21/2020 10/22/2020 10/23/2020 Date
321.26(c) 320.44(c) 317.85(c) 325.92(c) 323.55(c) Last
1 012 476 685 533 553 143 818 725 756 079 Volume
-1.55% -0.26% -0.81% +2.54% -0.73% Change
More quotes
Financials (USD)
Sales 2020 3 095 M - -
Net income 2020 550 M - -
Net cash position 2020 2 068 M - -
P/E ratio 2020 87,9x
Yield 2020 -
Sales 2021 3 968 M - -
Net income 2021 941 M - -
Net cash position 2021 707 M - -
P/E ratio 2021 52,1x
Yield 2021 -
Capitalization 47 355 M 47 355 M -
EV / Sales 2020 14,6x
EV / Sales 2021 11,8x
Nbr of Employees 7 700
Free-Float 75,1%
More Financials
Company
Illumina, Inc. specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and biotechnology companies. Net sales break down by source of income as follows: - product sales (82.7%): tools and... 
More about the company
Notations Surperformance© of Illumina, Inc.
Trading Rating : Investor Rating :
More Ratings
All news about ILLUMINA, INC.
10/07ILLUMINA, INC. : Report
CO
10/05ILLUMINA, INC. : Report
CO
10/01ILLUMINA, INC. : Report
CO
09/28ILLUMINA : to Announce Third Quarter 2020 Financial Results on Thursday, October..
BU
09/25JOHNSON & JOHNSON, NIKE, ILLUMINA : Stocks That Defined the Week
DJ
09/23ILLUMINA : to Webcast Upcoming Investor Conference Presentation
BU
09/21Nikola, Illumina fall; Cubic, Rent-A-Center rise
AQ
09/21Nikola, Illumina fall; Cubic, Rent-A-Center rise
AQ
09/21Illumina to buy Jeff Bezos-backed cancer testing firm Grail in £6.23 billion ..
RE
09/21JEFF BEZOS : Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 b..
RE
09/21ILLUMINA, INC. : Entry into a Material Definitive Agreement, Other Events (form ..
AQ
09/21ILLUMINA : Correction to Illumina Acquisition of Grail Article
DJ
09/21FRANCIS DESOUZA : Sequencing Firm Illumina to Pay $7.1 Billion for Liquid-Biopsy..
DJ
09/21ILLUMINA : Confirms Deal For Grail
DJ
09/21Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 bln deal
RE
More news
News in other languages on ILLUMINA, INC.
09/21ILLUMINA : bietet für Krebstest-Hersteller Grail acht Milliarden Dollar
09/21WALL STREET STOCK EXCHANGE : Les valeurs à suivre à Wall Street
09/21Illumina will Krebsdiagnose-Spezialisten Grail kaufen
09/03ILLUMINA : collabore avec 54gene à la création d'une installation de génomique d..
09/03ILLUMINA : arbeitet mit 54gene bei der Schaffung einer Genomik-Einrichtung von W..
More news
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | ILMN | US4523271090 | MarketScreener
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 18
Average target price 297,25 $
Last Close Price 323,55 $
Spread / Highest target 17,4%
Spread / Average Target -8,13%
Spread / Lowest Target -32,0%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Robert P. Ragusa Senior Vice President-Global Quality & Operations
Sam A. Samad Chief Financial Officer & Senior Vice President
Phillip G. Febbo Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA, INC.-2.47%47 355
THERMO FISHER SCIENTIFIC47.80%189 950
DANAHER CORPORATION51.59%165 276
INTUITIVE SURGICAL, INC.24.42%86 460
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.95.16%64 541
BOSTON SCIENTIFIC CORPORATION-17.80%53 178